Cloned (Comment) | Organism |
---|---|
recombinant expression of the CCP1-CCP2-SP fragment of enzyme MASP-1 in Escherichia coli | Homo sapiens |
Crystallization (Comment) | Organism |
---|---|
in complex with Schistocerca gregaria protease inhibitor-2 variant VCTKLWCN, to 1.28 A resolution. Structure reveals significant plasticity of the protease | Homo sapiens |
MASP-1 catalytic domain in complex with protease inhibitor SGPI-1, recombinant CCP1-CCP2-SP fragment of MASP-1 and SGMI-1 inhibitor are mixed in a 2:3 molar ratio and concentrated to 5 mg/ml, hanging drop vapor diffusion method, mixing of 0.001 ml of protein and 0.001 ml of reservoir solution comprising 0.1 M HEPES, pH 7.0, 25% PEG 1000, 0.3 M NaNO3, at 20°C, crystal structure determination and analysis at 3.2 A resolution, molecular replacement | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
ACTRKLCW | a Schistocerca gregaria protease inhibitor-1 P4-P4' sequence mutant | Homo sapiens | |
MCTRKLCW | a Schistocerca gregaria protease inhibitor-1 P4-P4' sequence mutant | Homo sapiens | |
MCTRKLCY | a Schistocerca gregaria protease inhibitor-1 P4-P4' sequence mutant | Homo sapiens | |
additional information | no inhibition by Schistocerca gregaria protease inhibitor-2, SGMI-2, and sunflower MASP inhibitor-2, SFMI-2, but slight inhibition by inhibitor mutants, overview; Schistocerca gregaria protease inhibitor-2 variant VCTKLWCN is specific for isoform MASP-2 and not inhibitory for isoform MASP-1 | Homo sapiens | |
Schistocerca gregaria protease inhibitor-1 | SGMI-1, sequence P4-P4' is FCTRKLCY, the structure of the MASP-1-SGMI-1 complex does not support the induced fit or conformational selection substrate-binding model, structure analysis, detailed overview | Homo sapiens | |
Schistocerca gregaria protease inhibitor-2 variant FCTRKLCY | randomization of positions P4, P2, P1, P1', P2', and P4' of the protease binding loop while keeping the structurally indispensable Cys at P3 and P3' leads to monospecific MASP inhibitors. Inhibitor variant FCTRKLCY is specific for isoform MASP-1, treatment completely blocks the lectin pathway activation, demonstrating that MASP-1 is not an auxiliary but an essential pathway component | Homo sapiens | |
sunflower MASP inhibitor-1 | SFMI-1, sequence P4-P4' is ICSRSLPP | Homo sapiens | |
VCTRLWCE | a sunflower MASP inhibitor-2 P4-P4' sequence mutant, only slight inhibition | Homo sapiens | |
VCTRLWCN | a sunflower MASP inhibitor-2 P4-P4' sequence mutant, only slight inhibition | Homo sapiens | |
VCTRLYCN | a sunflower MASP inhibitor-2 P4-P4' sequence mutant, only slight inhibition | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P48740 | - |
- |
Synonyms | Comment | Organism |
---|---|---|
MASP-1 | - |
Homo sapiens |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.000007 | - |
Schistocerca gregaria protease inhibitor-2 variant FCTRKLCY | pH not specified in the publication, temperature not specified in the publication | Homo sapiens | |
0.000007 | - |
Schistocerca gregaria protease inhibitor-1 | pH and temperature not specified in the publication, recombinant enzyme | Homo sapiens | |
0.000014 | - |
MCTRKLCY | pH and temperature not specified in the publication, recombinant enzyme | Homo sapiens | |
0.00002 | - |
MCTRKLCW | pH and temperature not specified in the publication, recombinant enzyme | Homo sapiens | |
0.000027 | - |
ACTRKLCW | pH and temperature not specified in the publication, recombinant enzyme | Homo sapiens | |
0.000065 | - |
sunflower MASP inhibitor-1 | pH and temperature not specified in the publication, recombinant enzyme | Homo sapiens | |
0.087 | - |
VCTRLWCN | pH and temperature not specified in the publication, recombinant enzyme | Homo sapiens | |
0.153 | - |
VCTRLWCE | pH and temperature not specified in the publication, recombinant enzyme | Homo sapiens | |
0.176 | - |
VCTRLYCN | pH and temperature not specified in the publication, recombinant enzyme | Homo sapiens |
General Information | Comment | Organism |
---|---|---|
metabolism | target binding of pattern recognition molecules leads to the activation of zymogen mannan-binding lectin-associated serine proteases and triggers the lectin pathway, an antibody-independent activation route of the complement system, which provides immediate defense against pathogens and altered self-cells, but also causes severe tissue damage after stroke, heart attack, and other ischemia reperfusion injuries. MASP-2 and MASP-1 are both essential pathway components | Homo sapiens |